Baseimmune is discovery stage biotech developing universal vaccines with variant-proof antigens. The technology is based on a platform that uses big-data analysis of genomic and epidemiological data to design multi-strain antigens for universal vaccines.
Baseimmune has now started manufacturing and pre-clinical testing of 3 vaccines against human and veterinary diseases including African Swine Fever.
London BioScience Innovation Centre
2 Royal College Street
London
NW1 0NH
United Kingdom
Tel: +44 (0) 20 7691 1122